Article
DNA Nanoflower Enables Controlled Co-Delivery of Antisense Oligodeoxynucleotide and Doxorubicin for Anti-breast Cancer Treatment
2025-02-21
Abstract excerpt
Doxorubicin (DOX), an anthracycline antibiotic, is widely used to treat a range of solid tumors and hematological malignancies. However, its clinical application in breast cancer is hindered by toxic side effects and the development of multidrug resistance (MDR). Enhancing the selective targeting of DOX and overcoming MDR are critical to improving treatment efficacy. Here, we present a DNA nanoflower (DNF)-based d...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 60669e70-6528-5621-9fb3-5c53d059d711
- DOI
- 10.22541/au.174017526.63124569/v1
